GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (LSE:CTEC) » Definitions » ROE % Adjusted to Book Value

ConvaTec Group (LSE:CTEC) ROE % Adjusted to Book Value : 2.54% (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group ROE % Adjusted to Book Value?

ConvaTec Group's ROE % for the quarter that ended in Jun. 2024 was 9.37%. ConvaTec Group's PB Ratio for the quarter that ended in Jun. 2024 was 3.69. ConvaTec Group's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 2.54%.


ConvaTec Group ROE % Adjusted to Book Value Historical Data

The historical data trend for ConvaTec Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group ROE % Adjusted to Book Value Chart

ConvaTec Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 2.14 2.30 1.11 2.08

ConvaTec Group Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.72 0.51 2.07 2.41 2.54

Competitive Comparison of ConvaTec Group's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, ConvaTec Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ConvaTec Group's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ConvaTec Group's ROE % Adjusted to Book Value falls into.



ConvaTec Group ROE % Adjusted to Book Value Calculation

ConvaTec Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=7.74% / 3.73
=2.08%

ConvaTec Group's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.37% / 3.69
=2.54%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ConvaTec Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ConvaTec Group Business Description

Traded in Other Exchanges
Address
20 Eastbourne Terrace, 7th Floor, Paddington, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.

ConvaTec Group Headlines